News
12-16-2014, 03:13 AM
A new combination of cancer drugs delayed disease progression for patients with hormone-receptor-positive metastatic breast cancer, according to a multi-center phase II trial.
More... (http://www.medicalnewstoday.com/releases/286881.php)
More... (http://www.medicalnewstoday.com/releases/286881.php)